Yongmin Yan

9.8k total citations · 5 hit papers
103 papers, 7.8k citations indexed

About

Yongmin Yan is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Yongmin Yan has authored 103 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 33 papers in Genetics and 32 papers in Cancer Research. Recurrent topics in Yongmin Yan's work include Extracellular vesicles in disease (33 papers), Mesenchymal stem cell research (33 papers) and MicroRNA in disease regulation (25 papers). Yongmin Yan is often cited by papers focused on Extracellular vesicles in disease (33 papers), Mesenchymal stem cell research (33 papers) and MicroRNA in disease regulation (25 papers). Yongmin Yan collaborates with scholars based in China, United States and Ghana. Yongmin Yan's co-authors include Hui Qian, Wenrong Xu, Xu Zhang, Fei Mao, Wei Zhu, Bin Zhang, Mei Wang, Daoyan Wei, Xiangsheng Zuo and Bingying Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Yongmin Yan

99 papers receiving 7.7k citations

Hit Papers

Exosomes Derived from Human Umbilical Cord Mesenchymal St... 2012 2026 2016 2021 2012 2013 2015 2018 2023 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis
    2012 709 citations Yongmin Yan, Bingying Wang et al. Stem Cells and Development profile →
  2. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro
    2013 516 citations Wenrong Xu, Bingying Wang et al. profile →
  3. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
    2015 492 citations Yongmin Yan, Xiangsheng Zuo et al. profile →
  4. Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction
    2018 354 citations Yaoxiang Sun, Hui Shi et al. ACS Nano profile →
  5. Exosomal circRNA: emerging insights into cancer progression and clinical application potential
    2023 122 citations Yongmin Yan, Wenrong Xu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yongmin Yan China 45 5.5k 2.9k 2.0k 1.2k 919 103 7.8k
Bin Zhang China 43 6.3k 1.2× 3.4k 1.2× 1.6k 0.8× 886 0.7× 767 0.8× 177 9.1k
Fei Mao China 44 4.1k 0.8× 2.3k 0.8× 1.4k 0.7× 944 0.8× 798 0.9× 136 6.4k
Cristina Grange Italy 41 5.8k 1.1× 2.9k 1.0× 1.3k 0.7× 1.2k 1.0× 1.1k 1.2× 98 7.6k
Beate Heissig Japan 33 5.1k 0.9× 2.4k 0.8× 1.6k 0.8× 870 0.7× 2.6k 2.9× 74 8.7k
Koichi Hattori Japan 33 4.9k 0.9× 2.1k 0.7× 1.3k 0.6× 891 0.7× 2.3k 2.5× 64 7.7k
Ralf Hass Germany 45 3.8k 0.7× 1.6k 0.5× 2.4k 1.2× 1.4k 1.1× 2.1k 2.2× 151 7.5k
Alison Sullivan United States 9 5.7k 1.0× 1.4k 0.5× 1.6k 0.8× 2.0k 1.6× 1.4k 1.5× 9 8.3k
Radhika Pochampally United States 38 3.5k 0.6× 2.0k 0.7× 2.7k 1.3× 1.4k 1.2× 1.2k 1.3× 59 6.6k
Wei Cao China 39 2.5k 0.5× 1.5k 0.5× 1.3k 0.6× 818 0.7× 958 1.0× 146 5.8k

Countries citing papers authored by Yongmin Yan

Since Specialization
Citations

This map shows the geographic impact of Yongmin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongmin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongmin Yan more than expected).

Fields of papers citing papers by Yongmin Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongmin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongmin Yan. The network helps show where Yongmin Yan may publish in the future.

Co-authorship network of co-authors of Yongmin Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Yongmin Yan. A scholar is included among the top collaborators of Yongmin Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongmin Yan. Yongmin Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Wei, et al.. (2025). Ribosome biogenesis: A central player in liver diseases. Genes & Diseases. 12(5). 101512–101512. 1 indexed citations
2.
3.
Yan, Yongmin, et al.. (2024). Exosomes: Emerging Insights into the Progression of Pancreatic Cancer. International Journal of Biological Sciences. 20(10). 4098–4113. 5 indexed citations
4.
Chen, Yifei, et al.. (2024). RNF31 alleviates liver steatosis by promoting p53/BNIP3-related mitophagy in hepatocytes. Free Radical Biology and Medicine. 219. 163–179. 10 indexed citations
5.
6.
7.
Liu, Jinwen, et al.. (2022). Role of Exosomes in Chronic Liver Disease Development and Their Potential Clinical Applications. Journal of Immunology Research. 2022. 1–15. 25 indexed citations
8.
Yuan, Jintao, Jingyan Wang, Xiu Jun Cai, et al.. (2020). Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils. Inflammopharmacology. 28(2). 603–616. 33 indexed citations
9.
Sun, Yaoxiang, Hui Shi, Siqi Yin, et al.. (2018). Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destruction. ACS Nano. 12(8). 7613–7628. 354 indexed citations breakdown →
10.
Xie, Victoria K., Zhiwei Li, Yongmin Yan, et al.. (2017). DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression. Clinical Cancer Research. 23(18). 5585–5597. 36 indexed citations
11.
Mao, Fei, Jingjing Kang, Xiu Jun Cai, et al.. (2017). Crosstalk between mesenchymal stem cells and macrophages in inflammatory bowel disease and associated colorectal cancer. Współczesna Onkologia. 2(2). 91–97. 17 indexed citations
12.
Mao, Fei, Yunbing Wu, Xudong Tang, et al.. (2017). Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages. Biotechnology Letters. 39(6). 929–938. 29 indexed citations
13.
Yan, Yongmin, Zhiwei Li, Xiangyu Kong, et al.. (2016). KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. Cancer Research. 76(8). 2419–2431. 56 indexed citations
14.
Zhang, Bin, Li Shen, Hui Shi, et al.. (2016). Exosomes from Human Umbilical Cord Mesenchymal Stem Cells: Identification, Purification, and Biological Characteristics. Stem Cells International. 2016(1). 1929536–1929536. 102 indexed citations
15.
Wei, Daoyan, Liang Wang, Yongmin Yan, et al.. (2016). KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis. Cancer Cell. 29(3). 324–338. 109 indexed citations
16.
Yan, Yongmin, Wenqian Jiang, Jingwen Liu, Wenrong Xu, & Hui Qian. (2016). Expression of Recombinant Phosphodiesterases 3A and 3B Using Baculovirus Expression System. Iranian Journal of Biotechnology. 14(4). 236–242. 2 indexed citations
17.
Yan, Yongmin, Bingying Wang, Hui Qian, et al.. (2012). Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis. Stem Cells and Development. 22(6). 845–854. 709 indexed citations breakdown →
18.
Qian, Qian, Hui Qian, Xu Zhang, et al.. (2011). 5-Azacytidine Induces Cardiac Differentiation of Human Umbilical Cord-Derived Mesenchymal Stem Cells by Activating Extracellular Regulated Kinase. Stem Cells and Development. 21(1). 67–75. 115 indexed citations
19.
Chen, Yuan, Hui Qian, Wei Zhu, et al.. (2010). Hepatocyte Growth Factor Modification Promotes the Amelioration Effects of Human Umbilical Cord Mesenchymal Stem Cells on Rat Acute Kidney Injury. Stem Cells and Development. 20(1). 103–113. 81 indexed citations
20.
Sun, Xiaochun, Hui Qian, Wei Zhu, et al.. (2010). Mesenchymal stem cells isolated from human uterine cervix cancer tissues. Cell Biology International. 35(2). 119–123. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Zhang Breakdown of academic impact, for papers by Fei Mao Breakdown of academic impact, for papers by Cristina Grange Breakdown of academic impact, for papers by Beate Heissig Breakdown of academic impact, for papers by Koichi Hattori Breakdown of academic impact, for papers by Ralf Hass Breakdown of academic impact, for papers by Alison Sullivan Breakdown of academic impact, for papers by Radhika Pochampally Breakdown of academic impact, for papers by Wei Cao
Rankless by CCL
2026